These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8100555)

  • 1. Comparison of five histopathologic methods to assess cellular proliferation in transitional cell carcinoma of the urinary bladder.
    Cohen MB; Waldman FM; Carroll PR; Kerschmann R; Chew K; Mayall BH
    Hum Pathol; 1993 Jul; 24(7):772-8. PubMed ID: 8100555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of morphometry, nucleolar organizer regions, proliferating cell nuclear antigen and Ki67 antigen expression with grading and staging in urinary bladder carcinomas.
    Krüger S; Müller H
    Br J Urol; 1995 Apr; 75(4):480-4. PubMed ID: 7788260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Bromodeoxyuridine incorporation and PCNA expression as measures of cell proliferation in transitional cell carcinoma of the urinary bladder.
    Waldman FM; Carroll PR; Cohen MB; Kerschmann R; Chew K; Mayall BH
    Mod Pathol; 1993 Jan; 6(1):20-4. PubMed ID: 8093979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression.
    Cher ML; Chew K; Rosenau W; Carroll PR
    Prostate; 1995 Feb; 26(2):87-93. PubMed ID: 7855002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferative activity of urothelial neoplasms: comparison of BrdU incorporation, Ki67 expression, and nucleolar organiser regions.
    Limas C; Bigler A; Bair R; Bernhart P; Reddy P
    J Clin Pathol; 1993 Feb; 46(2):159-65. PubMed ID: 8459037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ki-67 scores and AgNor counts in transitional cell carcinoma of the bladder: apparent lack of prognostic value.
    Zambelli S; Zanin A; Gaglio A; Zai G; Bosco E; Andrion A; Magnani C
    Arch Ital Urol Androl; 1993 Dec; 65(6):665-70. PubMed ID: 8312949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative assessment of proliferating cell nuclear antigen immunostaining and of nucleolar organizer region staining in transitional cell carcinomas of the urinary bladder. Correlation with other conventional prognostic pathologic parameters.
    Skopelitou A; Korkolopoulou P; Papanicolaou A; Christodoulou P; Thomas-Tsagli E; Pavlakis K
    Eur Urol; 1992; 22(3):235-40. PubMed ID: 1361436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor.
    Tomobe M; Shimazui T; Uchida K; Hinotsu S; Akaza H
    J Urol; 1999 Jul; 162(1):63-8. PubMed ID: 10379741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of proliferating cell nuclear antigen, Ki-67 and nucleolar organizer region in transitional cell carcinoma of the bladder.
    Bozlu M; Orhan D; Baltaci S; Yaman O; Elhan AH; Tulunay O; Müftüoğlu YZ
    Int Urol Nephrol; 2002; 33(1):59-66. PubMed ID: 12090340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of mitotic indices, AgNor count, Ki-67 and Bcl-2 with grade and stage in papillary urothelial bladder cancer.
    Goyal S; Singh UR; Sharma S; Kaur N
    Urol J; 2014 Mar; 11(1):1238-47. PubMed ID: 24595931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of proliferative markers Ki-67 (MIB-1) and proliferating cell nuclear antigen (PC10) in transitional cell carcinoma of the renal pelvis.
    Cheville JC; Terrell RB; Cohen MB
    Mod Pathol; 1994 Sep; 7(7):794-800. PubMed ID: 7824516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PCNA/cyclin expression in transitional cell carcinomas of the human bladder: its correlation with Ki-67 and epidermal growth factor receptor immunostainings.
    Serio G
    Pathologica; 1994 Apr; 86(2):161-6. PubMed ID: 7936759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell proliferation of human bladder tumors determined by BrdUrd and Ki-67 immunostaining.
    Tsujihashi H; Nakanishi A; Matsuda H; Uejima S; Kurita T
    J Urol; 1991 Apr; 145(4):846-9. PubMed ID: 2005717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional differences in bromodeoxyuridine uptake, expression of Ki-67 protein, and nucleolar organizer region counts in glioblastoma multiforme.
    Onda K; Davis RL; Wilson CB; Hoshino T
    Acta Neuropathol; 1994; 87(6):586-93. PubMed ID: 8091951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of prognostic value of nucleolar organizer region enumeration in transitional cell carcinoma of the bladder.
    Mansour P; Crocker J; Newman J
    Arch Pathol Lab Med; 1990 Dec; 114(12):1261. PubMed ID: 1701296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of bromodeoxyuridine labeling index, Ki-67 score and Ag-NOR count in breast carcinomas. Comparison with DNA ploidy.
    Sasaki K; Matsumura K; Murakami T; Tsuji T
    Oncology; 1992; 49(2):147-53. PubMed ID: 1574251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Morphometric, cytochemical and immunohistochemical studies on the proliferative activity of urinary bladder carcinomas].
    Krüger S; Kahl M; Fabian T; Hörlin A; Herrmann G; Müller H; Schneider M
    Verh Dtsch Ges Pathol; 1993; 77():231-5. PubMed ID: 7511287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silver-stained nucleolar organizer region analysis for cellular proliferation.
    Cserni G
    Hum Pathol; 1994 Feb; 25(2):215-6. PubMed ID: 8119726
    [No Abstract]   [Full Text] [Related]  

  • 19. Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer.
    Waldman FM; Carroll PR; Kerschmann R; Cohen MB; Field FG; Mayall BH
    Cancer Res; 1991 Jul; 51(14):3807-13. PubMed ID: 1676611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
    Kale A; Söylemez F; Ensari A
    Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.